In a move that could help save the hearing of thousands of people with TB, the World Health Organisation (WHO) is advising wider use of newer and repurposed drugs, bedaquiline and linezolid in place of injections that cause deafness.
By Lucy Gilson, Jane Goudge, Uta Lehmann, Helen Schneider The publication of the National Health Insurance (NHI) and Medical Schemes Amendment Bills in June this year is an indication of the…
While AIDS deaths and the rate of new HIV infections in South Africa are declining, the country seems set to miss crucial UNAIDS and National Strategic Plan targets. Around 89 000…
After decades of relying on isoniazid-based TB preventive therapy as the best option for TB prevention, a number of new regimens have done well in clinical trials and at least some of them will soon be rolled out.
Spotlight published an opinion piece this week with leaked information about UNAIDS Executive Director Michel Sidibe’s correspondence with McKinsey and Company and senior UN leaders. The piece by AIDS-Free World…
WHO launched new interim guidance on HIV treatment at AIDS 2018 recommending dolutegravir (DTG) for everyone aged six years and above. [1, 2] But access to DTG for women and adolescent…
There is a perception that AIDS activism is largely dead, that the AIDS activists have “retired”. There is a narrative and belief among some that there is a serious and…
For over 30 years activism has been the engine that has driven almost every advance in our response to the AIDS epidemic. Mark Heywood assesses the state of activism in…
According to leaked information about UNAIDS Executive Director Michel Sidibe's correspondence with McKinsey and Company, 2018 will mark the beginning of the end of UNAIDS: the embattled leader has hatched…
By Ellen 't Hoen As the world gathers in Amsterdam for the 22nd International AIDS Conference, high medicines prices are again making headlines across the world. Ellen 't Hoen takes…
There are many reasons why the end of the AIDS epidemic is not yet in sight and why the International AIDS Conference still matters, writes IAS President Linda-Gail Bekker. The…
The 90-90-90 targets have become key indicators against which to measure our progress in the HIV response. A new Human Sciences Research Council survey provides some estimates of how we are doing.